Ledger.Open graph →
SEC Form D · filed September 14, 2017

Nivagen Pharmaceuticals, Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SACRAMENTO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Jwalant Shukla · Sacramento, CAExec · DirectorSharad Dadbhawala · Campbell, CADirectorJwalant Shukla · Sacramento, CAExec · DirectorBikram Singh · Morganville, NJDirectorAshish Sevak · Paramus, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗